参考文献/References:
[1] 陈伟伟,高润霖,刘力生,等.《中国心血管病报告2016》概要[J].中国循环杂志,2017,32(6):521-530.
[2] Anderson JL,Morrow DA.Acute myocardial infa rction[J].N Engl J Med,2017,376(21): 2053-2064.
[3] Bergmann O,Bhardwaj RD,Bernard S,et al.Evidence for cardiomyocyte renewal in humans [J].Science,2009,324(5923):98-102.
[4] Senyo SE,Steinhauser ML,Pizzimenti CL,et al.Mammalian heart renewal by pre-existing cardiomyocytes[J].Nature,2013,493(7432):433-436.
[5] Porrello ER,Mahmoud AI,Simpson E,et al.Transient regenerative potential of the neonatal mouse heart[J].Science,2011,331(6020):1078-1080.
[6] Menasche P.Cell therapy trials for heart regeneration—lessons learned and future directions[J].Nat Rev Cardiol,2018,15(11):659-671.
[7] Li Y,He L,Huang X,et al.Genetic lineage tracing of nonmyocyte population by dual recombinases[J].Circulation,2018,138(8):793-805.
[8] Eschenhagen T,Bolli R,Braun T,et al.Cardiomyocyte regeneration: a consensus statement [J].Circulation,2017,136(7):680-686.
[9] Galdos FX,Guo Y,Paige SL,et al.Cardiac regeneration: lessons from development[J]. Circ Res,2017,120(6):941-959.
[10]Sayed D,Abdellatif M.MicroRNAs in development and disease[J].Physiol Rev,2011, 91(3):827-887.
[11] 马天雪,赵玉娟.长链非编码RNA及相关调控通路与急性心肌梗死的研究进展[J].心血管病学进展,2019,40(8):1099-1103.
[12]Hodgkinson CP,Kang MH,Dal-Pra S,et al.MicroRNAs and cardiac regen eration[J].Circ Res,2015,116(10):1700-1711.
[13] Eulalio A,Mano M,Dalferro M,et al.Functional screening identifies miRNAs inducing cardiac regeneration[J].Nature,2012,492(7429):376-381.
[14] Chen J,Huang ZP,Seok HY,et al.miR-17-92 cluster is required for and sufficient to induce cardiomyocyte proliferation in postnatal and adult hearts[J].Circ Res,2013, 112(12):1557-1566.
[15]Tian Y,Liu Y,Wang T,et al.A microRNA-Hippo pathway that promotes cardiomyocyte proliferation and cardiac regeneration in mice[J].Sci Transl Med,2015,7(279): 279ra38.
[16]Lesizza P,Prosdocimo G,Martinelli V,et al.Single-dose intracardiac injection of pro-regenerative micr oRNAs improves cardiac function after myocardial infarction [J].Circ Res,2017,120(8):1298-1304.
[17]Kwon Y,Vinayagam A,Sun X,et al.The Hippo signaling pathway interactome[J].Science, 2013,342(6159):737-740.
[18]Flinn MA,Link BA,O’Meara CC.Upstream regulation of the Hippo-YAP pathway in cardiomyocyte regeneration[J].Semin Cell Dev Biol, 2020,100:11-19.
[19]Ardestani A,Lupse B,Maedler K.Hippo signaling: key emerging pathway in cellular and whole-body metabolism [J].Trends Endocrinol Metab,2018,29(7):492-509.
[20]von Gise A,Lin Z,Schlegelmilch K,et al.YAP1,the nuclear target of Hippo signaling, stimulates heart growth through cardiomyocyte proliferation but not hypertrophy[J]. Proc Natl Acad Sci USA,2012,109(7):2394-2399.
[21]Lin Z,von Gise A,Zhou P,et al.Cardiac-specific YAP activation improves cardiac function and survival in an experimental murine MI model[J].Circ Res,2014,115(3): 354-363.
[22] Monroe TO,Hill MC,Morikawa Y,et al.YAP partially reprograms chromatin accessibility to directly induce adult cardiogenesis in vivo[J].Dev Cell,2019, 48(6):765-779.e7.
[23] Leach JP,Heallen T,Zhang M,et al.Hippo pathway deficiency reverses systolic heart failure after infarction[J].Nature,2017,550(7675):260-264.
[24]Diez-Cunado M,Wei K,Bushway PJ,et al.miRNAs that induce human cardiomyocyte proliferation converge on the Hippo p athway[J].Cell Rep,2018,23(7):2168-2174.
[25] Torrini C,Cubero RJ,Dirkx E,et al.Common regulatory pathways mediate activity of microRNAs inducing cardiomyocyte proliferation[J].Cell Rep,2019,27(9): 2759-2771.e5.
[26] Zhao B,Li L,Tumaneng K,et al.A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP)[J].Genes Dev,2010,24(1):72-85.
[27] Xie Y, Wang Q, Gao N, et al. MircroRNA-10b promotes human embryonic stem cell-derived cardiomyocyte proliferation via novel target gene LATS1 [J]. Mol Ther Nucleic Acids, 2019, 19：437-445.
[28] Dupont S,Morsut L,Aragona M,et al.Role of YAP/TAZ in mechanotransduction[J].Nature, 2011,474(7350):179-183.
[29]Chang L,Azzolin L,di Diagio D,et al.The SWI/SNF complex is a mechanoregulated inhibitor of YAP and TAZ[J].Nature,2018,563(7730):265-269.
[30]Lee JY,Dominguez AA,Nam S,et al.Identification of cell context-dependent YAP-associated proteins reveals beta1 and beta4 integrin mediate YAP translocation independently of cell spreading[J].Sci Rep,2019,9(1):17188.
[31] Lee J,Manoharan V,Cheung L,et al.Nanoparticle-based hybrid scaffolds for deciphering the role of multimodal cues in cardiac tissue engineering[J].ACS Nano, 2019,13(11):12525-12539.
[32] Judd J,Lovas J,Huang GN.Defined factors to reactivate cell cycle activity in adult mouse cardiomyocytes[J].Sci Rep,2019,9(1):18830.
[33]Li X,He X,Wang H,et al.Loss of AZIN2 splice variant facilitates endogenous cardiac regeneration[J].Cardiovasc Res,2018,114(12):1642-1655.
[34] Deng S,Zhao Q,Zhen L,et al.Neonatal heart-en riched miR-708 promotes proliferation and stress resistance of cardiomyocytes in rodents[J].Theranostics,2017,7(7): 1953-1965.
[35]Borden A,Kurian J,Nickoloff E,et al.Transient introduction of miR-294 in the heart promotes cardiomyocyte cell cycle reentry after injury[J].Circ Res,2019,125(1): 14-25.
[36] Wang J,Chen X,Shen D,et al.A long noncoding RNA NR_045363 controls cardiomyocyte proliferation and cardiac repair[J].J Mol Cell Cardiol,2019,127:105-114.
[37]Trivedi CM,Zhu W,Wang Q,et al.Hopx and Hdac2 interact to modulate Gata4 acetylation and embryonic cardiac myocyte proliferation[J].Dev Cell,2010,19(3):450-459.
[38]Gabisonia K,Prosdocimo G,Aquaro GD,et al.MicroRNA therapy stimulates uncontrolled cardiac repair after myocardial infarction in pigs[J].Nature,2019,569(7756): 418-422.
[39] Ikeda S,Mizushima W,Sciarretta S,et al.Hippo deficiency leads to cardiac dysfunction accompanied by cardiomyocyte dedifferentiation during pressure overload[J].Circ Res,2019,124(2):292-305.
相似文献/References:
[1]林远龙,刘现亮.无复流现象:从基础到临床[J].心血管病学进展,2016,(1):53.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.014]
LIN Yuanlong,LIU Xianliang.From Bench to Bed:No-reflow Phenomenon[J].Advances in Cardiovascular Diseases,2016,(7):53.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.014]
[2]赵劲东,综述,董平栓,等.合并多支血管病变的急性ST段抬高型心肌梗死介入术治疗策略的研究进展[J].心血管病学进展,2016,(3):295.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.021]
ZHAO Jindong,DONG Pingshuan.Research Progress of Interventional Therapy in Patients with ST-elevation
Myocardial Infarction and Multivessel Disease[J].Advances in Cardiovascular Diseases,2016,(7):295.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.021]
[3]余正春,综述,马小静,等.急性心肌梗死并发心源性休克的治疗进展[J].心血管病学进展,2016,(4):441.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.029]
YU Zhengchun,MA Xiaojing.Treatment of Cardiogenic Shock Complicating Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2016,(7):441.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.029]
[4]袁帅,毛玉琳,钱志敏,等.经皮冠脉介入术在高龄老年患者治疗中的研究新进展[J].心血管病学进展,2019,(6):864.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.007]
YUAN Shuai,MAO Yulin,QIAN Zhimin,et al.New Progress in Study of PCI in treatment of Elderly Patients[J].Advances in Cardiovascular Diseases,2019,(7):864.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.007]
[5]元洋洋 李波.Selvester QRS评分系统研究进展[J].心血管病学进展,2019,(7):985.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.005]
YUAN YangyangLI Bo.Research Progress of Selvester QRS Scoring System[J].Advances in Cardiovascular Diseases,2019,(7):985.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.005]
[6]翁子骞 于波.血栓抽吸在急性ST段抬高型心肌梗死中的研究进展[J].心血管病学进展,2019,(7):1035.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.018]
WENG ZiqianYU Bo.Thrombus aspiration in acute ST-segment elevation myocardial infarction[J].Advances in Cardiovascular Diseases,2019,(7):1035.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.018]
[7]林莉 韦铁民.急性心肌梗死后心脏破裂[J].心血管病学进展,2019,(7):1039.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.019]
LIN LiWEI Tiemin.Post-infarction Cardiac Rupture[J].Advances in Cardiovascular Diseases,2019,(7):1039.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.019]
[8]黄淮滨 刘甲兴.肥厚型心肌病治疗新靶点——钙脱敏治疗[J].心血管病学进展,2019,(7):1047.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.021]
HUANG HuaibinLIU Jiaxing.A Novel Target for Therapy in Hypertrophic Cardiomyopathy: Ca2+ desensitizer[J].Advances in Cardiovascular Diseases,2019,(7):1047.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.021]
[9]杨颜瑜,苏星,谭敏,等.炎症指标与急性心肌梗死研究进展[J].心血管病学进展,2019,(6):947.[doi:10.16806/j.cnki.issn.1004-3934.2019.0.027]
YANG Yanyu,SU Xing,TAN Min,et al.Relationship Between Inflammation Index and Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2019,(7):947.[doi:10.16806/j.cnki.issn.1004-3934.2019.0.027]
[10]崔小豪 杨志明.和肽素在急性心肌梗死中的研究进展[J].心血管病学进展,2019,(5):726.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.016]
CUI Xiaohao,YANG Zhiming.Copeptin in Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2019,(7):726.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.016]